XBiotech (XBIT) Competitors $2.76 +0.09 (+3.37%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$2.76 +0.01 (+0.18%) As of 09/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIT vs. UPXI, RCKT, ABEO, CGC, FDMT, ALT, ALDX, FHTX, LRMR, and CTNMShould you be buying XBiotech stock or one of its competitors? The main competitors of XBiotech include Upexi (UPXI), Rocket Pharmaceuticals (RCKT), Abeona Therapeutics (ABEO), Canopy Growth (CGC), 4D Molecular Therapeutics (FDMT), Altimmune (ALT), Aldeyra Therapeutics (ALDX), Foghorn Therapeutics (FHTX), Larimar Therapeutics (LRMR), and Contineum Therapeutics (CTNM). These companies are all part of the "pharmaceutical products" industry. XBiotech vs. Its Competitors Upexi Rocket Pharmaceuticals Abeona Therapeutics Canopy Growth 4D Molecular Therapeutics Altimmune Aldeyra Therapeutics Foghorn Therapeutics Larimar Therapeutics Contineum Therapeutics XBiotech (NASDAQ:XBIT) and Upexi (NASDAQ:UPXI) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Do insiders and institutionals hold more shares of XBIT or UPXI? 55.7% of XBiotech shares are owned by institutional investors. Comparatively, 5.7% of Upexi shares are owned by institutional investors. 30.8% of XBiotech shares are owned by company insiders. Comparatively, 4.4% of Upexi shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor XBIT or UPXI? In the previous week, Upexi had 2 more articles in the media than XBiotech. MarketBeat recorded 3 mentions for Upexi and 1 mentions for XBiotech. XBiotech's average media sentiment score of 1.46 beat Upexi's score of 0.79 indicating that XBiotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment XBiotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Upexi 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate XBIT or UPXI? Upexi has a consensus target price of $15.50, suggesting a potential upside of 127.27%. Given Upexi's stronger consensus rating and higher probable upside, analysts plainly believe Upexi is more favorable than XBiotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score XBiotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Upexi 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has more risk and volatility, XBIT or UPXI? XBiotech has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Upexi has a beta of -0.47, indicating that its stock price is 147% less volatile than the S&P 500. Is XBIT or UPXI more profitable? XBiotech has a net margin of 0.00% compared to Upexi's net margin of -135.86%. XBiotech's return on equity of -15.60% beat Upexi's return on equity.Company Net Margins Return on Equity Return on Assets XBiotechN/A -15.60% -14.64% Upexi -135.86%-535.19%-122.94% Which has better earnings & valuation, XBIT or UPXI? Upexi has higher revenue and earnings than XBiotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXBiotech$4.01M20.99-$38.53M-$0.92-3.00Upexi$26M15.45-$23.66MN/AN/A SummaryXBiotech beats Upexi on 8 of the 15 factors compared between the two stocks. Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XBIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIT vs. The Competition Export to ExcelMetricXBiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$81.40M$3.12B$5.78B$10.26BDividend YieldN/A2.37%5.74%4.64%P/E Ratio-3.0021.3676.7426.98Price / Sales20.99422.62512.93165.01Price / CashN/A45.3237.1760.63Price / Book0.469.6913.536.37Net Income-$38.53M-$52.92M$3.29B$271.46M7 Day Performance0.36%2.19%1.57%2.53%1 Month Performance-14.02%8.96%6.82%9.42%1 Year Performance-65.28%10.84%77.92%30.16% XBiotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBITXBiotech1.9747 of 5 stars$2.76+3.4%N/A-63.2%$81.40M$4.01M-3.00100Positive NewsUPXIUpexi3.0743 of 5 stars$5.66-6.3%$15.50+173.9%+62.4%$355.69M$26M0.00130Gap UpRCKTRocket Pharmaceuticals4.834 of 5 stars$3.26-0.6%$16.73+413.3%-84.8%$353.92MN/A-1.30240Short Interest ↑ABEOAbeona Therapeutics4.115 of 5 stars$6.70-2.8%$19.50+191.0%+3.5%$353.31M$3.50M9.5790Positive NewsCGCCanopy Growth1.0021 of 5 stars$1.35-7.5%N/A-71.1%$350.18M$225.65M-0.453,150Positive NewsOptions VolumeFDMT4D Molecular Therapeutics2.5367 of 5 stars$6.97-4.1%$30.40+336.2%-57.8%$339.53M$40K-1.97120Positive NewsALTAltimmune2.6271 of 5 stars$3.71-1.9%$17.40+369.0%-47.9%$333.61M$20K-3.1450ALDXAldeyra Therapeutics1.5577 of 5 stars$5.70+2.5%$9.50+66.7%-14.7%$333.02MN/A-6.7110FHTXFoghorn Therapeutics2.8718 of 5 stars$5.75-0.3%$10.67+85.5%-46.2%$326.18M$22.60M-4.83120News CoverageAnalyst UpgradeAnalyst RevisionGap UpLRMRLarimar Therapeutics2.7429 of 5 stars$3.93-0.3%$18.43+368.9%-37.5%$326.14MN/A-2.5230CTNMContineum Therapeutics2.5816 of 5 stars$12.13+5.5%$22.75+87.6%-32.9%$322.48M$50M-5.5131Short Interest ↑ Related Companies and Tools Related Companies UPXI Competitors RCKT Competitors ABEO Competitors CGC Competitors FDMT Competitors ALT Competitors ALDX Competitors FHTX Competitors LRMR Competitors CTNM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIT) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBIT Stock Alerts